InvestorsHub Logo
Followers 11
Posts 898
Boards Moderated 0
Alias Born 09/10/2019

Re: falconer66a post# 288697

Friday, 12/18/2020 4:29:46 AM

Friday, December 18, 2020 4:29:46 AM

Post# of 459834
Falconer, I've always appreciated your thoughts. Is it possible that with the different indications that Anavex is pursuing, that Dr M may ask for FDA approval for GABA and glutamate normalization, rather than a specific indication. That way if a person has a CNS disease with this problem, a doctor could prescribe it. There could be a so called list of diseases, that even though it had not been involved in a trial for your indication, blarcamesine would be an approved drug.
I know that this would be an entirely new approach, but the FDA needs to up it's game when it comes to Anavex. With the MOA that blarcamesine has, there has been nothing before that can compare. Your thoughts?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News